Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.

Front Med (Lausanne) · 2023 · PMC10079888 · PMID 37035331

Europe PMC DOI

hedged sentence

0.4930

closest p · 9.9× alpha

0.4930

boldest claim

The sentences

did not reach statistical significancep = 0.493not close (p > 0.1)

There was a slightly greater improvement of 38 mls in FVC in the cyclophosphamide arm of the trial by 24 weeks, but this did not reach statistical significance ( p = 0.493).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.